For research use only. Not for therapeutic Use.
An ipratropium-d3 bromide（Cat No.:S000331） is a deuterated form of ipratropium bromide, where three hydrogen atoms are replaced with deuterium. Ipratropium bromide is a bronchodilator used primarily in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. The introduction of deuterium atoms increases the molecule’s stability, enhancing the precision of pharmacokinetic and metabolic studies. This detailed analysis helps to better understand the drug’s absorption, distribution, metabolism, and excretion.
| Catalog Number | S000331 |
| Molecular Formula | C20H27D3BrNO3 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| IUPAC Name | [8-propan-2-yl-8-(trideuteriomethyl)-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;bromide |
| InChI | InChI=1S/C20H30NO3.BrH/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;/h4-8,14,16-19,22H,9-13H2,1-3H3;1H/q+1;/p-1/i3D3; |
| InChIKey | LHLMOSXCXGLMMN-FJCVKDQNSA-M |
| SMILES | CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.[Br-] |
